{
    "clinical_study": {
        "@rank": "9787", 
        "acronym": "Sacred", 
        "arm_group": [
            {
                "arm_group_label": "Positive group", 
                "description": "The groups who Clinical events happened"
            }, 
            {
                "arm_group_label": "Negative Group", 
                "description": "The groups who Clinical events have not happened"
            }
        ], 
        "brief_summary": {
            "textblock": "The investigators designed a clinical randomized trials,which established a registration\n      platform of antiplatelet therapy in patients with coronary heart disease,in order to\n      understand current situation of antithrombotic treatment in our country at present stage,and\n      to evaluate the popularity rate of antiplatelet therapy which is followed domestic and\n      international relevant guidelines in our country,finally analyse events risk factors of\n      blood clot and bleeding after antiplatelet therapy in patients with coronary heart disease."
        }, 
        "brief_title": "Optimized Scheme About Antiplatelet Therapy in Patients With Coronary Heart Disease", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Coronary Artery Disease", 
        "condition_browse": {
            "mesh_term": [
                "Coronary Artery Disease", 
                "Myocardial Ischemia", 
                "Coronary Disease", 
                "Heart Diseases"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion criteria:\n\n          1. Clinical diagnosis of coronary heart disease\n\n          2. Age should be full of 18 years old\n\n          3. Have been taking  anti-platelet  drugs\n\n          4. Informed consent signed\n\n        Exclusion Criteria:\n\n          1. With severe disease and life expectancy 6 months or less\n\n          2. The researchers think follow-up more difficult situation (travel, speech or mental\n             disorder, etc.)\n\n          3. Taking part in an intervening clinical research"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Patient of coronary heart disease"
            }
        }, 
        "enrollment": {
            "#text": "8000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 12, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01735305", 
            "org_study_id": "SYNH-20121113"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Coronary Artery Disease", 
            "antiplatelet therapy"
        ], 
        "lastchanged_date": "November 27, 2012", 
        "location": [
            {
                "contact": {
                    "last_name": "Jiyan Chen, MD", 
                    "phone": "15920520902"
                }, 
                "facility": {
                    "address": {
                        "city": "Guangzhou", 
                        "country": "China", 
                        "state": "Guangdong"
                    }, 
                    "name": "Guangdong General Hospital"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "hanyal@263.net", 
                    "last_name": "Yaling Han, Dr", 
                    "phone": "+86-24-23922184"
                }, 
                "facility": {
                    "address": {
                        "city": "Shenyang", 
                        "country": "China", 
                        "state": "Liaoning"
                    }, 
                    "name": "Northern Hospital"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_groups": "2", 
        "official_title": "Study of Optimized Scheme About Antiplatelet Therapy in Patients With Coronary Heart Disease", 
        "overall_contact": {
            "email": "13998847715@qq.com", 
            "last_name": "Yaling Han, MD", 
            "phone": "+86-24-23922184"
        }, 
        "overall_official": {
            "affiliation": "Shenyang Northern Hospital", 
            "last_name": "Yaling Han, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "China: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Cardiovascular death  Non cardiovascular death  Unexplained death", 
            "measure": "death", 
            "safety_issue": "Yes", 
            "time_frame": "12month"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01735305"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Shenyang Northern Hospital", 
            "investigator_full_name": "Yaling Han", 
            "investigator_title": "Head of Cardiology", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Lethal myocardial infarction PTCA or CABG hemorrhage Deadly stroke", 
            "measure": "Cardiovascular events", 
            "safety_issue": "No", 
            "time_frame": "12month"
        }, 
        "source": "Shenyang Northern Hospital", 
        "sponsors": {
            "collaborator": {
                "agency": "Guangdong General Hospital", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Shenyang Northern Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "November 2012"
    }
}